Research and Markets has announced the availability of a new report, that presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are also reviewed. The report is entitled “The 2011 Malaria Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country.”
The report provides the 5 and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks and strategic planning issues and concerns.
Key Topics Covered:
I. Introduction
II. Worldwide Market and Technology Overview
III. France: Test Volume and Diagnostics Sales Forecast by
IV. Germany: Test Volume and Diagnostics Sales Forecast by
V. Italy: Test Volume and Diagnostics Sales Forecast by
VI. Japan: Test Volume and Diagnostics Sales Forecast by
VII. Spain: Test Volume and Diagnostics Sales Forecast by
VIII. UK: Test Volume and Diagnostics Sales Forecast by
IX. USA: Test Volume and Diagnostics Sales Forecast by
X. Alternative Market Penetration Strategies
XI. Potential Market Entry Barriers and Risks
XII. Competitive Assessments
48 Companies Mentioned – Including:
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Binding Site
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Wampole Labs
- Zenith
- Zeus
More information: Research and Markets
Source: Business Wire
I am interested in your report but fail to understand whether developing countries, where malaria is so abundent are a aprt of the report or not. If not, could you please explain why. I would also appreciate seeing a true summary of the report before purchasing it. Many thanks and kind regards, Dr. Iris Good
The report you refer to covers the status and production of malaria diagnostic tests, while also covering information about malaria epidemiology and other topics. Given most of the technology mentioned in the summary (monoclonal antibodies, DNA assays, etc) are developed by companies in Europe, the US and Japan, I believe the report focuses on the markets of these countries. However, they do seem to discuss the application of diagnostic technology, and the current status of other aspects of malaria research, which would imply that the developing world (where, as you rightly state, the bulk of malaria cases are found) is also considered.
However, we at Malaria.com are not involved with this report directly in any way, and merely wanted to post the news of its publication, for the interest of our readers. As such, if you have any additional questions specifically about the content of the report, I suggest you contact the publishers/authors. On their website, there is an option to “Enquire before Buying” – the link is here: Research and Markets – Enquire before buying.